Pregnancy And Covid-19: How A Telehealth Company Is Combating Vaccination Hesitancy

  • 📰 ForbesWomen
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

Nigeria News News

Nigeria Nigeria Latest News,Nigeria Nigeria Headlines

Covid-19 has brought with it a need for better information about women’s healthcare, especially about vaccines and pregnancy. Female founders have found a way to provide accurate information and better care, using telemedicine.

In 2017 it raised $10.8 million in a Series A roundIn 2020, it raised $45 million in a Series C round."Pregnant women are a very tech-savvy bunch and open to telehealth," said Jane van Dis, MD, medical director at Maven. They're comfortable seeking information online about what's safe for them to eat and wear. What exercises are safe to do? Can they dye their hair? They're comfortable with video chat, webinars, messaging, or attending a Q&A session on Instagram.

At the beginning of the Covid-19 crisis, due to personal protective equipment shortages and social distancing mandates, pregnant women skipped their doctor appointments. Policies were such that women's partners could not be there during delivery. The restrictions were also devastating to women going through fertility treatment and were up against a ticking biological clock.

Women have a lot of questions and concerns. Maven addresses them using the same techniques that have been proving effective—video chats, webinars, messaging, and Instagram Q&As. The Johnson and Johnson vaccine is similar to the influenza vaccine. Tons of data show the safety of this type of vaccine. This vaccine has the additional benefit that antibodies women develop are passed on to the fetus in utero."I feel 100% confident in saying I have enough data to tell my patients that I think this vaccine is safe in pregnancy," said van Dis.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 477. in NG
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Nigeria Nigeria Latest News, Nigeria Nigeria Headlines